Structure-based understanding of ligand affinity using human thrombin as a model system.
about
Structural basis for chemical inhibition of human blood coagulation factor XaProton bridging in the interactions of thrombin with small inhibitorsCrystal structure of recombinant human tissue kallikrein at 2.0 A resolutionThe effect of the P1 side chain on the binding of optimized carboxylate and activated carbonyl inhibitors of the hepatitis C virus NS3 protease.The mechanism of binding of low-molecular-weight active site inhibitors to human alpha-thrombin.
P2860
Structure-based understanding of ligand affinity using human thrombin as a model system.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Structure-based understanding of ligand affinity using human thrombin as a model system.
@ast
Structure-based understanding of ligand affinity using human thrombin as a model system.
@en
type
label
Structure-based understanding of ligand affinity using human thrombin as a model system.
@ast
Structure-based understanding of ligand affinity using human thrombin as a model system.
@en
prefLabel
Structure-based understanding of ligand affinity using human thrombin as a model system.
@ast
Structure-based understanding of ligand affinity using human thrombin as a model system.
@en
P2093
P356
P1433
P1476
Structure-based understanding of ligand affinity using human thrombin as a model system.
@en
P2093
Kettner CA
Mersinger LJ
Nienaber VL
P304
P356
10.1021/BI952164B
P407
P577
1996-07-01T00:00:00Z